Sunday, November 3, 2024
Home Latest Health News Semaglutide-linked suicidal ideation identified in disproportionality analysis

Semaglutide-linked suicidal ideation identified in disproportionality analysis

by Medical Xpress
0 comment



Semaglutide-associated suicidal ideation has been identified in a disproportionality analysis, according to a study published online Aug. 20 in JAMA Network Open.

Georgios Schoretsanitis, M.D., Ph.D., from Northwell Health in Glen Oaks, New York, and colleagues examined potential signals for suicidal and self-injurious adverse (ADRs) associated with the glucagon-like peptide 1 receptor agonists and liraglutide in a disproportionality analysis. Participants were patients experiencing an ADR, which was suspected as attributable to semaglutide or liraglutide.

Overall, 107 and 162 cases of suicidal and/or self-injurious ADRs were reported between November 2000 and August 2023 for semaglutide and liraglutide, respectively. The researchers detected significant disproportionality for semaglutide-associated (reporting odds ratio, 1.45), which remained significant for those coreporting antidepressant and benzodiazepine use (reporting odds ratios, 4.45 and 4.07, respectively) and compared with dapagliflozin, metformin, and orlistat (reporting odds ratios, 5.56, 3.86, and 4.24, respectively).

“We reported a disproportionality signal of suicidal ideation with semaglutide, but not for liraglutide, particularly among patients with coreported antidepressant use, a proxy for affective disorders (a notable exclusion criteria of premarketing ),” the authors write.

One author disclosed ties to the biopharmaceutical industry.

More information:
Francesco Salvo et al, GLP-1 Receptor Agonists and Suicidality—Caution Is Needed, JAMA Network Open (2024). DOI: 10.1001/jamanetworkopen.2024.23335

© 2024 HealthDay. All rights reserved.

Citation:
Semaglutide-linked suicidal ideation identified in disproportionality analysis (2024, August 21)
retrieved 22 August 2024
from https://medicalxpress.com/news/2024-08-semaglutide-linked-suicidal-ideation-disproportionality.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.





Source link

You may also like

Leave a Comment

Edtior's Picks

Latest Articles

All Rights reserved, site designed by Yellohost.co.za